Aberrant RPE mTORC1 signaling in dysregulation of choroid homeostasis
异常 RPE mTORC1 信号传导导致脉络膜稳态失调
基本信息
- 批准号:10680452
- 负责人:
- 金额:$ 36.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The overall goal of the project is to delineate the cellular and molecular mechanisms that link dysfunction of the
retinal pigment epithelium (RPE) to degeneration of the choriocapillaris (CC). Choroidal atrophy is an early
pathological change in age-related macular degeneration (AMD), a leading cause of blindness in elderly
people. The RPE produces a number of trophic factors that support the structural integrity of the choroidal
vasculature. Aging and age-related degeneration can interfere with the functional interactions between the
RPE and CC. The underlying disease mechanisms are largely unclear. We found that the mouse model of
RPE-specific overactivation of the mechanistic target of rapamycin complex 1 (mTORC1) recapitulated many
of the clinical features of CC dropout. RPE cells with high mTORC1 activity had increased release of
angiopoietin 2 (ANGPT2), a vascular destabilizing factor that is usually produced by endothelial cells (ECs)
and exerts autocrine effects on its receptor TIE2. We further identified that the secretion of ANGPT2 from RPE
was likely mediated by the upregulation and activation of a phosphoprotein DARPP-32. Based on these novel
findings, we hypothesize that ANGPT2 production and secretion from the RPE contribute to the degeneration
of choroid under pathological conditions that involve dysregulated mTORC1 signaling. The hypothesis will be
tested in three specific aims. Aim 1 is to determine whether mTORC1 activation in the RPE will stimulate
ANGPT2 secretion via DARPP-32-dependent mechanisms. Aim 2 is to examine whether ANGPT2 can
regulate the function of choroidal ECs via TIE2-dependent or independent pathways. Aim 3 is to determine
whether genetic knockout of ANGPT2 in the RPE, or AAV-mediated overexpression of ANGPT2 will influence
the CC atrophy in the mouse model of mTORC1 hyperactivation. The results from these studies will provide
insights on how the AMD-related signaling events in the RPE impact its support to the CC. The newly identified
ANGPT2-TIE2 axis between the RPE and choroidal ECs can be a molecular pathway for the therapeutic
intervention of choroidal atrophy.
该项目的总体目标是描述连接的细胞和分子机制
视网膜色素上皮(RPE),脉络膜毛细血管(CC)的变性。脉络膜萎缩是早期的
年龄相关黄斑变性(AMD)的病理变化,这是老年失明的主要原因
人们。 RPE产生许多支持脉络膜结构完整性的营养因素
脉管系统。衰老和与年龄相关的变性会干扰
RPE和CC。潜在的疾病机制在很大程度上不清楚。我们发现鼠标模型
雷帕霉素复合物1(MTORC1)的机械靶标的RPE特异性过度活化概括了许多
CC辍学的临床特征。具有高MTORC1活性的RPE细胞增加了
血管生成素2(Angpt2),一种血管不稳定因子,通常由内皮细胞(ECS)产生
并对其受体TIE2发挥自分泌作用。我们进一步确定了rpe的angpt2分泌
可能是由磷酸蛋白Darpp-32的上调和激活介导的。基于这些小说
调查结果,我们假设RPE的Angpt2产生和分泌有助于退化
在病理条件下的脉络膜涉及MTORC1信号失调的病理条件下。假设将是
以三个特定目标进行测试。 AIM 1是确定RPE中的MTORC1激活是否会刺激
通过DARPP-32依赖性机制的Angpt2分泌。 AIM 2是检查Angpt2是否可以
通过TIE2依赖性或独立途径来调节脉络膜EC的功能。目标3是确定
RPE中ANGPT2的遗传敲除还是AAV介导的ANGPT2的过表达会影响
MTORC1过度激活小鼠模型中的CC萎缩。这些研究的结果将提供
关于RPE中与AMD相关的信号事件如何影响CC的洞察力。新确定的
RPE和脉络膜EC之间的Angpt2-Tie2轴可以是治疗性的分子途径
脉络膜萎缩的干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Yan Chen的其他基金
mTORC1-TFEB pathway in degeneration of the RPE
RPE 变性中的 mTORC1-TFEB 通路
- 批准号:93209509320950
- 财政年份:2016
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTORC1-TFEB pathway in degeneration of the RPE
RPE 变性中的 mTORC1-TFEB 通路
- 批准号:99861279986127
- 财政年份:2016
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTORC1-TFEB pathway in degeneration of the RPE
RPE 变性中的 mTORC1-TFEB 通路
- 批准号:91606609160660
- 财政年份:2016
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTORC1-TFEB pathway in degeneration of the RPE
RPE 变性中的 mTORC1-TFEB 通路
- 批准号:1000463210004632
- 财政年份:2016
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTOR-mediated Signaling Pathway in Aging of the Retinal Pigment Epithelium
mTOR 介导的视网膜色素上皮老化信号通路
- 批准号:87167628716762
- 财政年份:2012
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTOR-mediated Signaling Pathway in Aging of the Retinal Pigment Epithelium
mTOR 介导的视网膜色素上皮老化信号通路
- 批准号:85358878535887
- 财政年份:2012
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTOR-mediated Signaling Pathway in Aging of the Retinal Pigment Epithelium
mTOR 介导的视网膜色素上皮老化信号通路
- 批准号:85418588541858
- 财政年份:2012
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTOR-mediated Signaling Pathway in Aging of the Retinal Pigment Epithelium
mTOR 介导的视网膜色素上皮老化信号通路
- 批准号:79343707934370
- 财政年份:2010
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
mTOR-mediated Signaling Pathway in Aging of the Retinal Pigment Epithelium
mTOR 介导的视网膜色素上皮老化信号通路
- 批准号:81353388135338
- 财政年份:2010
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Increasing muscle mass resolves vascular dysfunction in obesity
增加肌肉质量可以解决肥胖症的血管功能障碍
- 批准号:1067936310679363
- 财政年份:2023
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
Deciphering Ang2/Tie2 signaling regulation of BBB disruption and neuroinflammation in Alzheimers disease
破译 Ang2/Tie2 信号对阿尔茨海默病 BBB 破坏和神经炎症的调节
- 批准号:1045215210452152
- 财政年份:2022
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
Developing a multivalent agent for long-lasting treatment of diabetic macular edema
开发用于长期治疗糖尿病黄斑水肿的多价药物
- 批准号:1032453410324534
- 财政年份:2021
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
完全修饰的双特异性适体可有效联合治疗新生血管性眼病
- 批准号:99098579909857
- 财政年份:2020
- 资助金额:$ 36.25万$ 36.25万
- 项目类别:
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
完全修饰的双特异性适体可有效联合治疗新生血管性眼病
- 批准号:1057864510578645
- 财政年份:2020
- 资助金额:$ 36.25万$ 36.25万
- 项目类别: